The present study demonstrates that DSS alleviates cognitive deficits in APP/PS1 mice by modulating the AMPK/Sp1/ACSL4 signalling axis to inhibit neuronal ferroptosis, providing a novel therapeutic strategy for AD. The gene discussed is APP; the disease is Alzheimer disease.